fetching data ...

POS1030 (2026)
ARTIFICIAL INTELLIGENCE FOR EARLY DIAGNOSIS OF BEHÇET’S SYNDROME BASED ON INITIAL PATIENT’S ENCOUNTER
Keywords: Diagnostic test, Artificial Intelligence
F. Hassan1,2, M. Omar3, G. Aswad2,4, A. Saab2,4, H. Jeries1,2, M. E. Naffaa1,2
1Galilee Medical Center, Rheumatology Unit, Nahariya, Israel
2Bar-Ilan University, Azrieli Faculty of Medicine, Safed, Israel
3Icahn School of Medicine at Mount Sinai, Division of Data-Driven and Digital Medicine (D3M), New York, United States of America
4Galilee Medical Center, Internal Medicine “E”, Nahariya, Israel

Background: Early diagnosis of Behçet’s syndrome (BS) remains challenging due to heterogeneous and evolving clinical presentations and the absence of a definitive diagnostic test. Classification criteria such as the International Study Group (ISG) and International Criteria for Behçet’s Disease (ICBD) may lack sensitivity at early or atypical stages, contributing to diagnostic delay. Artificial intelligence (AI), particularly large language models (LLMs), may assist clinicians by integrating complex unstructured clinical data to support earlier recognition of rare multisystem diseases including BS.


Objectives: To evaluate the diagnostic accuracy of a large language model (ChatGPT-5) in identifying Behçet’s syndrome based solely on first rheumatology visit documentation, and to assess the impact of disease-specific knowledge-augmented prompting on diagnostic performance.


Methods: We conducted a retrospective study of 60 treatment-naïve patients evaluated at a tertiary rheumatology clinic (2020–2024), including 29 patients with confirmed BS and 31 disease controls (rheumatoid arthritis, psoriatic arthritis, axial spondyloarthritis, systemic lupus erythematosus). All patients had no prior rheumatic diagnosis and completed ≥12 months of follow-up. Free-text clinical documentation from the initial visit was anonymized and analyzed in its original language. ChatGPT-5 was evaluated using a two-phase design: (1) baseline assessment and (2) reassessment after BS-specific knowledge-augmented prompting incorporating classification criteria, early and atypical manifestations, epidemiological context, and key differential features (Figure 1). For each case, the model generated the three most likely differential diagnoses. Diagnostic performance was compared with the final clinical diagnosis. Paired comparisons between phases were assessed using McNemar’s test.


Results: Among patients subsequently diagnosed with BS, 51.7% fulfilled ICBD criteria and 41.4% fulfilled ISG criteria at the first visit, while 48.3% met neither (Table 1). At baseline, ChatGPT-5 identified BS among the top three differential diagnoses in 82.8% of cases, increasing to 96.6% following knowledge-augmented prompting, with false negatives decreasing from five to one. The correct diagnosis was ranked first in 72.4% of cases at baseline versus 93.1% after knowledge-augmented prompting (p=0.041). At the first visit, the treating rheumatologist diagnosed BS in 65.5% and suspected BS in an additional 24.1% of cases. False-positive BS predictions among controls remained low (3.2% at baseline vs. 6.5% after prompting; p=1.00).


Conclusions: A large language model accurately identified BS from initial rheumatology visit notes and demonstrated significantly improved diagnostic ranking following disease-specific knowledge-augmented prompting without compromising specificity. These findings highlight the potential role of AI as a diagnostic adjunct to support early recognition of BS, particularly in patients with incomplete or atypical presentations. Larger, multicenter prospective studies are warranted to validate these results and define safe clinical integration.

Baseline characteristics of the study cohort

BS n=29 RA n=8 PsA n=7 axSpA n=8 SLE n=8
Age (mean±SD ) 35.8 ± 12.4 58.9 ± 12.5 50 ± 16.8 42.8 ± 17.3 36.2 ± 12
Gender, n (% )
Male 12 (41.4%) 3 (37.5%) 3 (42.9%) 6 (75%) 2 (25%)
Female 17 (56.6%) 5 (62.5%) 4 (57.1%) 2 (25%) 6 (75%)
Religion, n (% )
Jewish 3 (10.3%) 3 (37.5%) 3 (42.9%) 4 (50%) 3 (37.5%)
Muslim 17 (58.6%) 2 (42.9%) 3 (42.9%) 2 (25%) 4 (50%)
Druze 9 (31.0%) 3 (14.3%) 1 (14.3%) 1 (12.5%) 1 (12.5%)
Christian 0 (%) 0 (%) 0 (%) 1 (12.5%) 0 (0%)
Laboratory data available at initial visit, n (% ) 20 (69.0%) 8 (100%) 5 (71.4%) 3 (37.5%) 8 (100%)
BS features at first visit
Fulfilling ICBD criteria, n (%) 15 (51.7%) - - - -
Fulfilling ISG criteria, n (%) 12 (41.4%) - - - -
Not fulfilling either set of criteria, n (%) 14 (48.3%) - - - -
BS features through follow-up period
HLA-B51 positivity, n (%) 11/14 tested (78.6%)* - - - -
Expert diagnosis of BS** 2 (6.9%) - - - -

BS - Behçet’s syndrome; RA – Rheumatoid arthritis; PsA – Psoriatic arthritis; axSpA – axial spondyloarthritis; SLE - Systemic lupus erythematosus; ICBD - International Criteria for Behçet’s Disease; ISG - International Study Group; HLA-B51 - Human Leukocyte Antigen B*51;

* HLA-B51 testing performed in 14 patients; 15 patients (51.7%) were not tested.

** Expert diagnosis of BS – While these patients did not fulfill the ISG or ICBD classification criteria through follow-up period, a diagnosis of Behçet’s Syndrome (BS) was considered most likely by experts, given the complete clinical presentation.


REFERENCES: NIL.


Acknowledgments: NIL.


Disclosure of Interests: None declared.


DOI: annrheumdis-2026-eular.B.3578
Keywords: Diagnostic test, Artificial Intelligence
Citation: , volume 85, supplement 1, year 2026, page s1098
Session: Poster View VII (Poster View)